DNA gyrase/Topo IV-IN-2 (Compound AK19) 是一种抗菌剂,对 E. coli DNA 旋转酶与拓扑异构酶 IV 的IC50分别为 0.783 μM和 7.136 μM。它对革兰氏阳性与革兰氏阴性病原体呈现广谱抗菌活性,并能抑制 B. subtilis 和 MRSA 的生物膜,其对 B. subtilis 和 MRSA 的MIC为 1.9 μM。此化合物适用于研究抗耐药菌药物。
IV-23, a potent inhibitor of cell growth both in vitro and in vivo, effectively reduces colony formation, arrests the cell cycle at the M phase, and induces apoptosis in esophageal squamous cell carcinoma through Noxa-mediated pathways. This compound emerges as a promising anticancer agent with significant potential.
AMD 3465 also potently inhibits the replication of X4 HIV strains (IC50: 1-10 nM). However, it has no effect on CCR5-using (R5) viruses. AMD 3465 (GENZ-644494) is a potent antagonist of CXCR4, inhibits binding of 12G5 mAb and CXCL12AF647 to CXCR4, with IC
MIV-150 is a nonnucleoside inhibitor of reverse transcriptase (NNRT). MIV-150 also blocking HIV-1 and HIV-2 infections (EC50<1 nM against HIV-1/HIV-2MN).